EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Blood-Based Biomarker Candidates in Screening for Colorectal Cancer

Mathias M Petersen, Jakob Kleif, Jason Liggett, Morten Rasmussen, Lars N Jørgensen, Jakob B Seidelin, Claudia Jaensch, Jesper Vilandt, Kåre A Gotschalck, Peter Bondeven, Uffe Schou Løve, Berit Andersen und 4 weitere

Clinical Colorectal Cancer · 2025

DOI: 10.1016/j.clcc.2025.10.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Colorectal Cancer, 2025. Verfasst von Mathias M Petersen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Gastro Unit, Surgical Section, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark; Institute for Clinical Medicine, University o…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Biomarkers, Tumor, Early Detection of Cancer, Adenoma. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Torben and Alice Frimodts Fund, Dansk Kræftforsknings Fond, Axel Muusfeldts Fond.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Blood-based biomarkers could be an alternative method to increase compliance in population-based screening programs for early detection of colorectal cancer (CRC). We aimed to identify blood-based biomarkers that can identify patients with early-stage asymptomatic CRC for use in national screening programs. MATERIALS AND METHODS: In a nested cohort of 1982 participants with a positive fecal immunochemical test (FIT, with > 100 ng Hemoglobin/mL) from the Danish CRC screening program, serum levels of 18 blood-based biomarkers (including GDF-15, hepsin, IL-8, keratin 1/10, L1CAM, MIA, MCP-1, NSE, OPG, AFP, CD44, CATD, TWEAK, YKL-40, CEA, midkine, osteonectin and ferritin) were measured. Biomarkers associated to CRC after adjusting for various possible confounders were combined with age and sex in a predictive multivariable model for CRC. RESULTS: Complete biomarker and clinical data were collected from 1959 subjects, including 237 (12.1%) with CRC and 623 (31.8%) with advanced adenomas. IL-8 was unaffected by confounders, increased across the adenoma-carcinoma progression, and associated to CRC (OR: 1.83, 95% CI, 1.59-2.11, P < .01) even when restricting analyses to early-stage CRC (OR: 1.41, 95% CI, 1.15-1.73, P < .01). Combining IL-8, OPG, CEA, ferritin, and age resulted in an AUC of 0.717 (0.682-0.751) for discriminating subjects with and without CRC. CONCLUSION: Application of blood-based biomarker panels consisting of colorectal neoplasia-associated proteins seem to be potential predictors for early detection of CRC. Especially IL-8 could have a significant impact on future screening models, though further testing in true screening cohorts is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsBiomarkers, TumorEarly Detection of CancerAdenomaHumansMaleFemaleMiddle AgedAgedMass ScreeningOccult BloodDenmarkInterleukin-8

Stichwörter der Autor:innen

Colon cancerEarly detectionPopulation-based screeningPredictive biomarkersRectal cancer

Substanzen

Biomarkers, TumorInterleukin-8

Autor:innen und Institutionen

  • Gastro Unit, Surgical Section, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark; Institute for Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Gastro Unit, Surgical Section, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark; Institute for Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Department of Surgery, Copenhagen U…
  • New Day Diagnostic, Knoxville, Tennessee, USA.
  • Institute for Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Digestive Disease Center, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark.
  • Gastro Unit, Section for Gastroenterology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.
  • Department of Surgery, Regional Hospital Gødstrup, Gødstrup, Denmark; NIDO | Center for Research and Education, Regional Hospital Gødstrup, Gødstrup, Denmark.

Förderung

  • Torben and Alice Frimodts Fund
  • Dansk Kræftforsknings Fond
  • Axel Muusfeldts Fond
  • Dagmar Marshalls Fond
  • Eva and Henry Frænkel Memorial Foundation
  • Augustinus Fonden
  • Poul and Ellen Hertz&apos;s Fund
  • Minister Erna Hamilton&apos;s Scholarship for Science and Art

Zitieren

APA

Petersen, M. M., Kleif, J., Liggett, J., Rasmussen, M., Jørgensen, L. N., Seidelin, J. B., Jaensch, C., Vilandt, J., Gotschalck, K. A., Bondeven, P., Løve, U. S., Andersen, B., Christensen, I. J., Fritsche, H. A., Mayer, E., & Therkildsen, C. (2025). Novel Blood-Based Biomarker Candidates in Screening for Colorectal Cancer. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2025.10.007

Vancouver

Petersen MM, Kleif J, Liggett J, Rasmussen M, Jørgensen LN, Seidelin JB, et al. Novel Blood-Based Biomarker Candidates in Screening for Colorectal Cancer. Clinical Colorectal Cancer. 2025. doi:10.1016/j.clcc.2025.10.007

BibTeX
@article{Petersen2025,
  author = {Petersen, Mathias M and Kleif, Jakob and Liggett, Jason and Rasmussen, Morten and Jørgensen, Lars N and Seidelin, Jakob B and Jaensch, Claudia and Vilandt, Jesper and Gotschalck, Kåre A and Bondeven, Peter and Løve, Uffe Schou and Andersen, Berit and Christensen, Ib J and Fritsche, Herbert A and Mayer, Eric and Therkildsen, Christina},
  title = {Novel Blood-Based Biomarker Candidates in Screening for Colorectal Cancer},
  journal = {Clinical Colorectal Cancer},
  year = {2025},
  doi = {10.1016/j.clcc.2025.10.007}
}
Kostenlos starten →